Source: Frontiers in Immunology. Unidades: FCF, FM
Subjects: COLITE, DOENÇA DE CROHN, RECEPTORES, PEPTÍDEOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Marina de Paula et al. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, v. 12, p. 1-12 art. 714138, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.714138. Acesso em: 18 nov. 2024.APA
Silva, M. de P., Rocha, G. H. O. da, Broering, M. F., Queiroz, M. L., Sandri, S., Loiola, R. A., et al. (2021). Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, 12, 1-12 art. 714138. doi:10.3389/fimmu.2021.714138NLM
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2021.714138Vancouver
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2021.714138